An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to Human Drug Compounding and Drug Supply Chain Security, and for Other Purposes
| An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to Human Drug Compounding and Drug Supply Chain Security, and for Other Purposes |
| Pubbl/distr/stampa | [Washington, D.C.] : , : [U.S. Government Printing Office], , [2013] |
| Descrizione fisica | 1 online resource (54 unnumbered pages) |
| Soggetto topico |
Pharmaceutical industry - United States - Quality control
Pharmaceutical industry - Security measures - United States Drugs - Dosage forms - United States - Quality control Drug adulteration - United States - Prevention Drugs - Marketing - Corrupt practices - United States - Prevention Product counterfeiting - United States - Prevention |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910704917503321 |
| [Washington, D.C.] : , : [U.S. Government Printing Office], , [2013] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001
| Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Printing Office, , 2001 |
| Descrizione fisica | 1 online resource (iii, 191 pages) : illustrations |
| Soggetto topico |
Drugs - Inspection - United States
Drug adulteration - Government policy - United States Pharmaceutical industry - United States - Quality control |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Continuing concerns over imported pharmaceuticals |
| Record Nr. | UNINA-9910708356803321 |
| Washington : , : U.S. Government Printing Office, , 2001 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Counterfeit bulk drugs : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000
| Counterfeit bulk drugs : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000 |
| Pubbl/distr/stampa | Washington : , : U.S. Government Printing Office, , 2000 |
| Descrizione fisica | 1 online resource (iii, 423 pages) : illustrations |
| Soggetto topico |
Drugs - Inspection - United States
Drugs - Standards - United States Drug adulteration - Government policy - United States Pharmaceutical industry - United States - Quality control Product counterfeiting - United States |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Counterfeit bulk drugs |
| Record Nr. | UNINA-9910706954803321 |
| Washington : , : U.S. Government Printing Office, , 2000 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Drug compounding pharmacies : risk and oversight issues / / Seth Sharpe, editor
| Drug compounding pharmacies : risk and oversight issues / / Seth Sharpe, editor |
| Pubbl/distr/stampa | [Hauppauge] New York : , : Nova Publishers, , [2013] |
| Descrizione fisica | 1 online resource (184 pages) |
| Disciplina | 338.4/76151 |
| Collana |
Pharmacology, research, safety testing and regulation
Public health in the 21st century |
| Soggetto topico |
Pharmaceutical technology - Standards
Pharmaceutical industry - United States - Quality control Products liability - Drugs - United States |
| ISBN | 1-62808-177-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910151722103321 |
| [Hauppauge] New York : , : Nova Publishers, , [2013] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The FDA and worldwide current good manufacturing practices and quality system requirements guidebook for finished pharmaceuticals / / José Rodríguez-Pérez
| The FDA and worldwide current good manufacturing practices and quality system requirements guidebook for finished pharmaceuticals / / José Rodríguez-Pérez |
| Autore | Rodríguez Pérez José <1961-> |
| Pubbl/distr/stampa | Milwaukee, Wisconsin : , : ASQ Quality Press, , [2014] |
| Descrizione fisica | 1 online resource (391 pages) |
| Disciplina | 338.476151 |
| Soggetto topico |
Pharmaceutical industry - United States - Quality control
Pharmaceutical industry - Production standards - United States Drugs - Standards |
| ISBN |
0-87389-828-1
0-87389-829-X 1-68015-784-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910797541903321 |
Rodríguez Pérez José <1961->
|
||
| Milwaukee, Wisconsin : , : ASQ Quality Press, , [2014] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The FDA and worldwide current good manufacturing practices and quality system requirements guidebook for finished pharmaceuticals / / José Rodríguez-Pérez
| The FDA and worldwide current good manufacturing practices and quality system requirements guidebook for finished pharmaceuticals / / José Rodríguez-Pérez |
| Autore | Rodríguez Pérez José <1961-> |
| Pubbl/distr/stampa | Milwaukee, Wisconsin : , : ASQ Quality Press, , [2014] |
| Descrizione fisica | 1 online resource (391 pages) |
| Disciplina | 338.476151 |
| Soggetto topico |
Pharmaceutical industry - United States - Quality control
Pharmaceutical industry - Production standards - United States Drugs - Standards |
| ISBN |
0-87389-828-1
0-87389-829-X 1-68015-784-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910814801203321 |
Rodríguez Pérez José <1961->
|
||
| Milwaukee, Wisconsin : , : ASQ Quality Press, , [2014] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Federal and state role in pharmacy compounding and reconstitution : exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003
| Federal and state role in pharmacy compounding and reconstitution : exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003 |
| Descrizione fisica | 1 online resource (iii, 145 p.) : ill |
| Soggetto topico |
Drugs - Dosage forms - United States - Evaluation
Pharmaceutical industry - United States - Quality control |
| Soggetto non controllato |
Drugs
Pharmaceutical industry Medical Business & economics |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Federal and state role in pharmacy compounding and reconstitution |
| Record Nr. | UNINA-9910689604203321 |
| Lo trovi qui: Univ. Federico II | ||
|
Guidance for industry [[electronic resource] ] : Q10 pharmaceutical quality system
| Guidance for industry [[electronic resource] ] : Q10 pharmaceutical quality system |
| Pubbl/distr/stampa | Silver Spring, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research |
| Descrizione fisica | i, 19 pages : digital, PDF file |
| Soggetto topico | Pharmaceutical industry - United States - Quality control |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Altri titoli varianti | Guidance for industry |
| Record Nr. | UNINA-9910698894403321 |
| Silver Spring, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, District of Columbia : , : National Academies Press, , [2012] |
| Descrizione fisica | 1 online resource (132 p.) |
| Disciplina | 615.1/9 |
| Soggetto topico |
Drug monitoring
Drug development - United States Drugs - United States - Design Pharmaceutical industry - United States - Quality control |
| Soggetto genere / forma | Electronic books. |
| ISBN | 0-309-26117-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN. |
| Record Nr. | UNINA-9910463950903321 |
| Washington, District of Columbia : , : National Academies Press, , [2012] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
| Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
| Pubbl/distr/stampa | Washington, District of Columbia : , : National Academies Press, , [2012] |
| Descrizione fisica | 1 online resource (132 p.) |
| Disciplina | 615.1/9 |
| Soggetto topico |
Drug monitoring
Drug development - United States Drugs - United States - Design Pharmaceutical industry - United States - Quality control |
| ISBN |
0-309-26119-8
0-309-26117-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN. |
| Record Nr. | UNINA-9910787308103321 |
| Washington, District of Columbia : , : National Academies Press, , [2012] | ||
| Lo trovi qui: Univ. Federico II | ||
| ||